
- The pharmaceutical industry, currently valued at USD 50 Bn and is expected to reach USD 130 Bn by 2030.
- The Indian pharmaceutical sector grew at a modest CAGR of 6.6 percent from 2016 to 2019 and it is predicted to rise at a CAGR of 12.3 percent from 2020 to 2030, attaining USD130 billion goal.
- The Indian pharmaceutical industry is the world's third largest by volume and fourteenth largest in terms of value.
- The COVID-19 pandemic has shown that India can not only innovate but also rapidly distribute time-critical drugs to every part of the globe.
- Indian medicines are preferred worldwide because of the low price and high quality, thereby rightly making the country the “pharmacy of the world”.
- Globally the country is the largest provider of generic drugs with a 20 percent share by volume and is known for its affordable vaccines and generic medications.
FICCI Pharma: Key Activities
- FICCI Pharma Team work closely with the government on policy issues, enhancing efficiency, competitiveness and expanding business opportunities for industry through a range of specialized services and global linkages. It also provides a platform for sector specific consensus building and networking. It has been actively involved in organizing stakeholder consultations/Roundtable Meetings, conferences and seminars, providing an opportunity for interaction between the industry and the policy makers, to identify the various impediments to the growth and functioning of the industry and to come out with prospective solutions.
- FICCI in partnership with the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers organizes the "India Pharma and India Medical Devices" annual flagship event in the pharma & Medical Device sector. This event provides a unique platform to the stakeholders to deliberate and address key issues, identify challenges and chart a road map for India to take a rightful place as a preferred destination of choice for Drug Discovery, Research & Development and Manufacturing to become globally competitive.
Team Leader
Manoj Mehta
Senior Director
Govt working on a scheme to strengthen Indian Medical Device sector: Secretary, Department of Pharmaceuticals, GoI
Dr Mansukh Mandaviya inaugurates 51 greenfield projects under PLI scheme for Bulk Drugs and Medical Devices
Bhagwanth Khuba, Union Minister of State for Chemicals & Fertilizers, GoI addresses valedictory session of ‘India MedTech Expo 2023’, Gandhinagar,Gujarat
Government has formulated a scheme namely ‘Promotion of Research and Innovation in Pharma MedTech Sector’
World eager to invest in India’s MedTech sector: Dr Mansukh Mandaviya
Govt adopting holistic approach to make India a global hub of Medical Devices, set to become $50 billion industry soon: Dr Mansukh Mandaviya

Curtain Raiser: India MedTech Expo 2023
Explore
2nd Pharmaceutical Task Force Meeting for development of a Self-Regulatory, Evidence-based code of marketing for antibiotics, focusing on the primary care setting, in association with Oasis Consortium
Explore
FICCI Pharma Working Group Meeting 2023
Explore
Multi-Stakeholder Workshop on "Role of Policy in enhancing awareness around Vaccine-Preventable Diseases"
ExploreDiscussion on Health System Sustainability & Resilience
ExploreCholesterol check must become part of diabetes and BP screening to improve India's Heart Health: Experts
National Round Table on Unmet needs in Heart Health - Elevating the under-rated risk factors
Explore
Pharmaceutical Task Force for development of a Self-Regulatory, Evidence-based code of marketing for antibiotics, focusing on the primary care setting, in association with Oasis Consortium
ExploreFICCI Pharma Committee Meeting 2022
Explore
Consultation on Evidence-based Marketing of Antibiotics in Association with Oasis Consortium
Explore
Transforming Healthcare Through Innovation & Integrated Services
Explore
Impact of the Pharma Industry on the Indian economy in the post-COVID era
Explore
7th International Conference on Pharmaceutical & Medical Device Sector
ExplorePharmacoeconomics can aid policy makers and healthcare providers in evaluating affordability and access to reasonable drug use: Dr Sangita Reddy, Immediate Past President, FICCI

Virtual Conclave on Integrating Methods of Pharmaco-economics to accelerate Healthcare Transformation 2.0 (IMPACT 2.0)
Explore
India Pharma 2021 & India Medical Device 2021
ExploreIndian Pharma market is expected to grow to US$ 130 billion by 2030: DV Sadananda Gowda

COVID Vaccine Rollout - Key Learning’s and preparedness for Phase 2
ExploreState governments geared up to tackle vision care during pandemic: Experts

Central and West conclave of the Spotlight on Visually Impaired in the wake of COVID-19
Explore
Pharmaceutical Technology - The Way Forward
ExploreNeed to create more awareness across the country on vision care: Industry Experts
Govt to soon formulate comprehensive eye care package for visually impaired: Economic Advisor, MoH&FW
e-Pharmacies can collaborate with CSCs to improve healthcare access in rural areas: MoS Health & Family Welfare

ePharmacies at COVID-19 Frontline
ExploreFICCI Statement on Bulk Drug Park and Production Linked Incentive (PLI) Scheme
FICCI applauds ICMR strategy for calibrated ramping up of the covid-19 testing
Govt to come up with regulatory guidelines for OTC drugs - Dy Drug Controller, MoH&FW
Quality, trust, transparency critical for the healthcare industry: Joint Secretary, Department of Commerce
Need for effective public health approach on the ground to control COVID-19: Dr V K Paul, Member, NITI Aayog
Industry should come forward to develop Pharma and Medical Devices parks - Mansukh Mandaviya
Virtual Healthcare & Hygiene Expo 2020
ExploreNeed to create more awareness in rural, tribal areas on Sickle Cell disease and its management - Arjun Munda
National Sickle Cell Conclave: World Sickle Cell Day 2020
ExploreFICCI launches first international 'Virtual Healthcare and Hygiene Expo 2020'

FICCI Recommendation on Regulatory Reforms for Pharma Sector in India
ExploreFICCI welcomes Cabinet decision on Bulk Drug Parks
India Pharma 2020 and India Medical Device 2020 focuses on clarity on changing regulatory scenarios

Reshaping India into a life sciences innovationhub
ExploreIndia Pharma 2020
ExploreIndia Medical Device 2020
ExploreIndian Analytical Congress - 2019
ExploreIndia Pavilion @ Pharmtech & Ingredients Expo
ExploreINDIA PAVILION AT PHARMATECH EXPO 2019
ExploreAccess to affordable medical care and National Health Protection Scheme, priority of Government: D V Sadananda Gowda
India Pharma 2019 & India Medical Device 2019 on 18-19 Feb. in Bengaluru
India Pavilion at Pharmtech & Ingredients Expo
Explore
India Pharma 2018: International Exhibition & Conference on Pharmaceutical Industry
Explore
Trends & Opportunities for Indian Pharma
Explore
Medical Value Travel in India: A Value Driven & Patient Centric Initiative
ExploreIndia Pavilion at INTERPHEX 2017
Explore
knowledge paper on "Towards Quality Excellence: Journey of the Indian Pharmaceutical Industry"
Explore
2nd International Exhibition & Conference on Pharmaceutical Industry
ExploreFICCI launches Self-regulation Code of Conduct for the e-pharmacy sector
FICCI welcomes Department of Pharmaceutical's move towards broadbased stakeholder consultations
Indian Pharma sector poised to become future world hub

Realising "Make in India"- Journey to become the most preferred manufacturer of high quality affordable medicines
Explore
Indian life sciences: Vision 2030 - Expanding global relevance and driving domestic access
Explore
FICCI Life Sciences Conference 2015 'Pharma Vision 2030: Building India's Global Relevance'
ExploreRegional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators” Focused on GMP in production of Active Pharmaceutical Ingredients and Oral Solid Dosage Forms
ExploreIndian Pharma Summit
ExploreGMP Strengthening for Indian Pharmaceutical Manufacturers focused on GMP in production of Active Pharmaceutical Ingredients and Oral Solid Dosage Forms
ExploreLeading journos recommend women to organize as pressure groups to increase their participation and numbers in politics

Position Paper: Enhancing India's Global Role in Supply of Generic Medicines
ExploreIndia Pharma Summit 2013-14
ExploreProlonged crisis in Ukraine could affect Indian pharma companies
Regional workshops on GMP Strengthening for Indian Pharmaceutical Manufacturers focused on GMP in production of Active Pharmaceutical Ingredients and Oral Solid Dosage Forms
Explore
Roundtable Discussion with Indian Pharmaceuticals & Diagnostics Industry Leaders & UNITAID Executive Director
Explore
Pharmerging shake-up
Explore
ACCESS TO Medicines & Global Outreach SUMMIT
Explore
India Pharma Summit-2012
Explore
India Pharma Summit
ExploreJoint China-India Tendering for Global Pharma Export Orders Possible Given China's Strengths in API Production, India's Capability in Formulations & Ability to Prepare Bid Documents: China Chamber
2nd India Pharma Summit
ExploreIndia Pharma Summit - 20100
ExploreIndia Pharma Summit 2009
Explore
Competition Law and Pharmaceutical Industry - Opportunities and Challenges
ExploreGlobal Pharma Companies Looking to India Advantage for Clinical Research Services: FICCI - E&Y Paper